Biointaxis hosts a webinar on how to invest in its gene therapy FRATAXAV® for Friedreich’s ataxia

by Biointaxis

Biointaxis, an academic spin-off from the Germans Trias i Pujol Research Institute (IGTP) founded in 2018, is developing the first drug designed to prevent and reverse the neurological and cardiac eff...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New breakthrough in developing more pers...

by Universitat de Barcelona

The results show that adenocarcinoma exhibits much more active and fun...

Photos Stream